Legend Stock Today

LEGN Stock  USD 63.38  0.24  0.38%   

Market Performance

11 of 100


Odds Of Distress

Less than 18

Legend BiotechCorp is selling at 63.38 as of the 3rd of June 2023; that is -0.38% down since the beginning of the trading day. The stock's open price was 63.62. Legend BiotechCorp has less than a 18 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. Equity ratings for Legend BiotechCorp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of December 2022 and ending today, the 3rd of June 2023. Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
5th of June 2020
Health Care
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. The company has 180.35 M outstanding shares of which 4.68 M shares are now shorted by private and institutional investors with about 3.7 trading days to cover. More on Legend BiotechCorp

Moving together with Legend Stock

+0.84DICEDice Molecules Holdings Fiscal Quarter End 30th of June 2023 PairCorr
+0.64DNLIDenali Therapeutics Fiscal Quarter End 30th of June 2023 PairCorr

Moving against Legend Stock

-0.81VBIVVBI Vaccines Fiscal Quarter End 30th of June 2023 PairCorr
-0.65DMTKDermTech Fiscal Quarter End 30th of June 2023 PairCorr
-0.61EQEquillium Fiscal Quarter End 30th of June 2023 PairCorr
-0.56VCNXVaccinex Fiscal Quarter End 30th of June 2023 PairCorr
-0.54AAgilent Technologies Fiscal Quarter End 31st of July 2023 PairCorr

Legend Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Legend BiotechCorp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Legend BiotechCorp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Average Analyst Recommendation
Analysts covering Legend BiotechCorp report their recommendations after researching Legend BiotechCorp's financial statements, talking to executives and customers, or listening in on Legend BiotechCorp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Legend BiotechCorp. The Legend consensus assessment is calculated by taking the average forecast from all of the analysts covering Legend BiotechCorp.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Legend BiotechCorp based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Legend BiotechCorp financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted317.4 M318.1 M
Slightly Down
Slightly volatile
Weighted Average Shares317.4 M318.1 M
Slightly Down
Slightly volatile
Net Cash Flow from Operations(215.6 M)(210 M)
Fairly Down
Slightly volatile
Current Liabilities269.6 M297.8 M
Moderately Down
Slightly volatile
Total Liabilities564.9 M586.7 M
Sufficiently Down
Slightly volatile
Gross Margin0.610.441
Significantly Up
Slightly volatile
Total Debt307 M284.5 M
Significantly Up
Slightly volatile
Asset Turnover0.10.095
Notably Up
Slightly volatile
Current Assets946.2 M1.1 B
Fairly Down
Slightly volatile
Total Assets1.2 B1.3 B
Fairly Down
Slightly volatile
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Legend BiotechCorp's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Legend BiotechCorp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Legend BiotechCorp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Legend BiotechCorp's financial leverage. It provides some insight into what part of Legend BiotechCorp's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Legend BiotechCorp's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Legend BiotechCorp deploys its capital and how much of that capital is borrowed.
Legend BiotechCorp cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 260.93 M in liabilities with Debt to Equity (D/E) ratio of 0.29, which may suggest the company is not taking enough advantage from borrowing. Legend BiotechCorp has a current ratio of 3.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Legend BiotechCorp until it has trouble settling it off, either with new capital or with free cash flow. So, Legend BiotechCorp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Legend BiotechCorp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Legend to invest in growth at high rates of return. When we think about Legend BiotechCorp's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(215.57 Million)
Legend BiotechCorp (LEGN) is traded on NASDAQ Exchange in USA. It is located in 2101 Cottontail Lane, Somerset, NJ, United States, 08873 and employs 1,390 people. Legend BiotechCorp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Legend BiotechCorp's market, we take the total number of its shares issued and multiply it by Legend BiotechCorp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Legend BiotechCorp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 180.35 M outstanding shares of which 4.68 M shares are now shorted by private and institutional investors with about 3.7 trading days to cover. Legend BiotechCorp currently holds about 791.26 M in cash with (200.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Check Legend BiotechCorp Probability Of Bankruptcy
Legend BiotechCorp maintains a total of one hundred eighty million three hundred fifty-one thousand eight outstanding shares. 30% of Legend BiotechCorp outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors.are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Legend Ownership Details

Legend Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Legend BiotechCorp jumping above the current price in 90 days from now is about 27.64%. The Legend BiotechCorp probability density function shows the probability of Legend BiotechCorp stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Legend BiotechCorp has a beta of 0.5581. This indicates as returns on the market go up, Legend BiotechCorp average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Legend BiotechCorp will be expected to be much smaller as well. Additionally, the company has an alpha of 0.5067, implying that it can generate a 0.51 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 63.38HorizonTargetOdds Above 63.38
72.27%90 days
Based on a normal probability distribution, the odds of Legend BiotechCorp to move above the current price in 90 days from now is about 27.64 (This Legend BiotechCorp probability density function shows the probability of Legend Stock to fall within a particular range of prices over 90 days) .

Legend Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Legend BiotechCorp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Legend BiotechCorp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Legend BiotechCorp's value.
InstituionLast TransactionTypeSharesValue
Fmr Llc2023-03-31Common Shares16.4 M790.6 M
Hhlr Advisors Ltd2023-03-31Common Shares5.1 M247.4 M
Blackrock Inc2023-03-31Common Shares4.1 M199 M
Ra Capital Management Lp2023-03-31Common Shares2.4 M117.5 M
Capital World Investors2023-03-31Common Shares2.4 M115.2 M
Federated Hermes Inc2023-03-31Common Shares2.3 M112.8 M
Polar Capital Holdings Plc2023-03-31Common SharesM95.3 M
Capital International Investors2023-03-31Common SharesM94.1 M
Janus Henderson Group Plc2023-03-31Common Shares1.9 M93.5 M
Wellington Management Group Llp2023-03-31Common Shares1.8 M84.7 M
Johnson Johnson2023-03-31Common Shares1.6 M78.6 M
View Legend BiotechCorp Diagnostics

Legend BiotechCorp Historical Income Statement

Legend BiotechCorp Income Statement is one of the three primary financial statements used for reporting Legend's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Legend BiotechCorp revenue and expense. Legend BiotechCorp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Legend BiotechCorp Gross Profit is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Gross Profit of 51.64 Million. As of 3rd of June 2023, Interest Expense is likely to grow to about 11.6 M, while Consolidated Income is likely to drop (458.1 M). View More Fundamentals

Legend Stock Against Markets

Picking the right benchmark for Legend BiotechCorp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Legend BiotechCorp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Legend BiotechCorp is critical whether you are bullish or bearish towards Legend BiotechCorp at a given time. Please also check how Legend BiotechCorp's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Earnings Calls Now


Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Legend BiotechCorp Corporate Management

Elected by the shareholders, the Legend BiotechCorp's board of directors comprises two types of representatives: Legend BiotechCorp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Legend. The board's role is to monitor Legend BiotechCorp's management team and ensure that shareholders' interests are well served. Legend BiotechCorp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Legend BiotechCorp's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Legend Stock?

Before investing in Legend BiotechCorp, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Legend BiotechCorp. To buy Legend BiotechCorp stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Legend BiotechCorp. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Legend BiotechCorp stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Legend BiotechCorp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Legend BiotechCorp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Legend BiotechCorp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Legend Stock please use our How to Invest in Legend BiotechCorp guide.

Already Invested in Legend BiotechCorp?

The danger of trading Legend BiotechCorp is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Legend BiotechCorp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Legend BiotechCorp. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Legend BiotechCorp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.